Skip to main content
Log in

The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administration

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Clodronate (dichloromethylene bisphosphonate) accumulates extensively in bone by binding to hydroxyapatite crystals. In an hypo-osmotic vehicle, it accumulates also in the spleen and, to a lesser extent, in the liver of mice and rats. In the present study, the effects of parenteral routes of administration (intravenous, intraperitoneal, and subcutaneous), drug dose, and injection vehicle on the distribution of [14C]-clodronate were studied in mice. The route of drug injection had no effect on the deposition of clodronate in bone. Either deionized water or iso-osmotic saline used as vehicles for intravenous administration of the drug caused equal and dose-dependent accumulation in bone. In iso-osmotic glucose, however, the osseous deposition of the drug was 2.2–2.5 times lower than in the other vehicles (water, saline, choline chloride). Clodronate accumulated in spleen and liver only after intravenous injection when the drug was in hypo-osmotic vehicle, and the process was saturable at high doses. The hypotonic vehicle probably causes a local hemolysis, and clodronate forms complexes with erythrocyte iron, which is a prerequisite for ingestion of the drug by splenic and hepatic macrophages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fleisch H. (1983): Bisphosphonates. Mechanism of action and clinical applications. In: Peck W.A. (ed.) Bone and Mineral Research, Annual 1. Amsterdam, Excerpta Medica, pp. 319–357.

    Google Scholar 

  2. Conrad K.A., Lee S.M. (1981): Clodronate kinetics and dynamics. Clin. Pharmacol. Ther., 30, 114–120.

    CAS  PubMed  Google Scholar 

  3. Pentikäinen P.J., Elomaa I., Nurmi A.-K., Kärkkäinen S. (1989): Pharmacokinetics of clodronate in patients with metastatic breast cancer. Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 222–228.

    PubMed  Google Scholar 

  4. Mönkkönen J., Ylitalo P., Elo H.A., Airaksinen M.M. (1987): Distribution of14C-clodronate (dichloromethylene bisphosphonate) disodium in mice. Toxicol. Appl. Pharmacol., 89, 287–292.

    Article  PubMed  Google Scholar 

  5. Mönkkönen J. (1988): A one year follow-up study of the distribution of14C-clodronate in mice and rats. Pharmacol. Toxicol., 62, 51–53.

    Article  PubMed  Google Scholar 

  6. Mönkkönen J., Urtti A., Paronen P., Elo H.A., Ylitalo P. (1989): The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab. Dispos., 17, 690–693.

    PubMed  Google Scholar 

  7. Harington J.S., Miller K., Macrab G. (1971): Hemolysis by asbestos. Envir. Res., 4, 95–117.

    Article  CAS  Google Scholar 

  8. Collan Y., Kosma V.-M., Anttonen H., Kulju T. (1986): Toxicity of richterite in hemolysis test and macrophage cultures. Arch. Toxicol., Suppl. 9, 292–295.

    CAS  Google Scholar 

  9. Michael W.R., King W.R., Wakim J.M. (1972): Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog, and monkey. Toxicol. Appl. Pharmacol., 21, 503–515.

    Article  CAS  PubMed  Google Scholar 

  10. Van Duzee B.F., Sumberg R.J., Benedict J.J. (1980): Effect of etidronate disodium on filterability of sickle erythrocytes. J. Pharm. Sci., 69, 599–600.

    Article  PubMed  Google Scholar 

  11. Goy W., Crowe W.J. (1976): Splenic accumulation of99mTc-diphosphonate in a patient with sickle cell disease: Case report. J. Nucl. Med., 17, 108–109.

    CAS  PubMed  Google Scholar 

  12. Winter P.F. (1976): Splenic accumulation of99mTc-diphosphonate. J. Nucl. Med., 17, 850.

    CAS  PubMed  Google Scholar 

  13. Van Rooijen N., Van Nieuwmegen R. (1984): Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res., 238, 355–358.

    Article  PubMed  Google Scholar 

  14. Mökkönen J., Koponen H.-M., Ylitalo P. (1990): Comparision of the distribution of three bisphosphonates in mice. Pharmacol. Toxicol., 66, 297–298.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mönkkönen, J., Ylitalo, P. The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice. The effects of vehicle and the route of administration. Eur. J. Drug Metab. Pharmacokinet. 15, 239–243 (1990). https://doi.org/10.1007/BF03190210

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190210

Keywords

Navigation